Corrigendum: Physiology and pharmacology of DPP-4 in glucose homeostasis and the treatment of type 2 diabetes (Frontiers in Endocrinology (2019) 10:80 DOI: 10.3389/fendo.2019.00080)

Abstract

In the original article, there was a mistake in Table 2 “Key published studies demonstrating the safety and tolerability of DPP-4 inhibitors” as published. Unfortunately, two of the citations were transposed in the table. The correct citation for the SAVOR-TIMI trial is Scirica et al. (2013): Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med 369: 1317–1326 (ref 127), while the correct citation for the TECOS trial is Green et al. (2015): Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes. N Engl J Med 373: 232–242, 2015 (ref 126). The corrected Table 2 appears below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated. (Table Presented).